{"entity":{"id":"breast-cancer-research","kind":"journal","name":"Breast cancer research","aka":["Breast cancer research : BCR","Breast Cancer Research","BCR","Breast Cancer Res"],"tldr":"Breast Cancer Research is an open access journal for laboratory, translational and clinical breast cancer science, read by breast cancer researchers and specialist clinicians.","summary":"Breast Cancer Research was launched in 1999 by BioMed Central in London and is published by BMC, part of Springer Nature. As its title indicates, it is devoted to research on breast cancer, from laboratory science to clinical studies, and its DOAJ and NLM records list it as an English journal published from London. It is fully open access and listed in DOAJ with CC BY and CC BY-NC-ND licences, an article processing charge and anonymous peer review, with open access content from 2000. Indexed in MEDLINE.","asOf":"2026-09-10","links":[{"label":"Homepage","url":"https://breast-cancer-research.biomedcentral.com/"},{"label":"NLM Catalog","url":"https://www.ncbi.nlm.nih.gov/nlmcatalog/100927353"},{"label":"DOAJ record","url":"https://doaj.org/toc/1465-5411"}],"tags":[],"related":["pubmed-europepmc"],"cancers":["breast-hr-positive","breast-her2-positive","tnbc","ductal-carcinoma-in-situ","male-breast-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"BMC (Springer Nature)","url":"https://breast-cancer-research.biomedcentral.com/","issn":"1465-5411","scope":"breast cancer","access":"open-access","founded":1999,"matchNames":["Breast Cancer Res","Breast cancer research","Breast Cancer Research"]},"route":"/journals/breast-cancer-research/","neighbours":{"collection":[{"id":"pubmed-europepmc","kind":"collection","name":"PubMed & Europe PMC","route":"/collections/pubmed-europepmc/"}],"cancer":[{"id":"ductal-carcinoma-in-situ","kind":"cancer","name":"Ductal carcinoma in situ (DCIS)","route":"/cancers/ductal-carcinoma-in-situ/"},{"id":"breast-her2-positive","kind":"cancer","name":"HER2-positive breast cancer","route":"/cancers/breast-her2-positive/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"male-breast-cancer","kind":"cancer","name":"Male breast cancer","route":"/cancers/male-breast-cancer/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"paper":[{"id":"paper-sigurjonsdottir-sp142-22c3-tnbc-bcr-2023","kind":"paper","name":"Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms","route":"/key-papers/paper-sigurjonsdottir-sp142-22c3-tnbc-bcr-2023/"},{"id":"paper-herschkowitz-rb1-loss-basal-like-bcr-2008","kind":"paper","name":"The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas","route":"/key-papers/paper-herschkowitz-rb1-loss-basal-like-bcr-2008/"}],"person":[{"id":"samantha-oakes","kind":"person","name":"Samantha Oakes","route":"/people/samantha-oakes/"},{"id":"senthil-muthuswamy","kind":"person","name":"Senthil K. Muthuswamy","route":"/people/senthil-muthuswamy/"}]}}